Dana L. Johnson

4.7k total citations · 1 hit paper
54 papers, 3.1k citations indexed

About

Dana L. Johnson is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dana L. Johnson has authored 54 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Immunology. Recurrent topics in Dana L. Johnson's work include Chemokine receptors and signaling (8 papers), Receptor Mechanisms and Signaling (5 papers) and DNA Repair Mechanisms (4 papers). Dana L. Johnson is often cited by papers focused on Chemokine receptors and signaling (8 papers), Receptor Mechanisms and Signaling (5 papers) and DNA Repair Mechanisms (4 papers). Dana L. Johnson collaborates with scholars based in United States, Germany and Norway. Dana L. Johnson's co-authors include Linda K. Jolliffe, Ian A. Wilson, E.A. Stura, Oded Livnah, Steven A. Middleton, Linda S. Mulcahy, P. H. Seeburg, Jean C. Shih, Michael E. Bembenek and C. W. Abell and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Dana L. Johnson

54 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

1988 606 citations Dana L. Johnson et al. profile →

Peers

Dana L. Johnson

ONCOL

IMMUN

HEMAT

RNMI

Rainer Albert Switzerland

Jun Wei China

José A. Halperin United States

John Matsoukas Greece

Dianne Watters Australia

J M Wood Switzerland

Mauro Bologna Italy

Tohru Sugimoto Japan

Mark A. Polokoff United States

Regina M. Day United States

Rainer Albert Switzerland

Dana L. Johnson

2.2k ×1.4

705 ×1.1

ONCOL

473 ×1.1

IMMUN

183 ×0.5

HEMAT

607 ×1.7

RNMI

Citations per year, relative to Dana L. Johnson Dana L. Johnson (= 1×) peers Rainer Albert

Countries citing papers authored by Dana L. Johnson

Since Specialization

Citations

This map shows the geographic impact of Dana L. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana L. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana L. Johnson more than expected).

Fields of papers citing papers by Dana L. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana L. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana L. Johnson. The network helps show where Dana L. Johnson may publish in the future.

Co-authorship network of co-authors of Dana L. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Dana L. Johnson. A scholar is included among the top collaborators of Dana L. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana L. Johnson. Dana L. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hinke, Simon A., Thomas Kirchner, Katharine D’Aquino, et al.. (2018). Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody. Molecular Metabolism. 10. 87–99. 12 indexed citations

Winters, Michael P., Christopher A. Teleha, Fu‐An Kang, et al.. (2014). The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2. Bioorganic & Medicinal Chemistry Letters. 24(9). 2137–2140. 5 indexed citations

Cai, Chaozhong, Cuifen Hou, John O’Neill, et al.. (2013). Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 24(4). 1239–1242. 5 indexed citations

Subasinghe, Nalin L., James C. Lanter, Evan E. Opas, et al.. (2012). A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(4). 1063–1069. 17 indexed citations

Cai, Chaozhong, Fu‐An Kang, Cuifen Hou, et al.. (2012). Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(1). 351–354. 6 indexed citations

Zhang, Xuqing, James C. Lanter, Chaozhong Cai, et al.. (2011). Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(18). 5577–5582. 18 indexed citations

Moore, Beverley A., Carl L. Manthey, Dana L. Johnson, & Anthony J. Bauer. (2011). Matrix Metalloproteinase-9 Inhibition Reduces Inflammation and Improves Motility in Murine Models of Postoperative Ileus. Gastroenterology. 141(4). 1283–1292.e4. 48 indexed citations

Moore, Beverley A., Nancy J. Peffer, Sarah Sague, et al.. (2010). GLP-2 Receptor Agonism Ameliorates Inflammation and Gastrointestinal Stasis in Murine Postoperative Ileus. Journal of Pharmacology and Experimental Therapeutics. 333(2). 574–583. 22 indexed citations

Perera, Timothy, Peter King, Laurence Mévellec, et al.. (2008). JNJ-38877605: a selective Met kinase inhibitor inducing regression of Met-driven tumor models.. Cancer Research. 68. 4837–4837. 20 indexed citations

10.

Arts, Janine, Patrick Angibaud, Wim Floren, et al.. (2007). R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. British Journal of Cancer. 97(10). 1344–1353. 77 indexed citations

11.

Santulli, Rosemary J., William A. Kinney, Shyamali Ghosh, et al.. (2007). Studies with an Orally Bioavailable αV Integrin Antagonist in Animal Models of Ocular Vasculopathy: Retinal Neovascularization in Mice and Retinal Vascular Permeability in Diabetic Rats. Journal of Pharmacology and Experimental Therapeutics. 324(3). 894–901. 41 indexed citations

12.

Moriarty, K.J.M., Holly K. Koblish, Thomas Garrabrant, et al.. (2006). The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: A new class of Aurora-A kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(22). 5778–5783. 54 indexed citations

13.

Kinney, William A., Li Liu, Shyamali Ghosh, et al.. (2004). Piperidine-containing β-arylpropionic acids as potent antagonists of αvβ3/αvβ5 integrins. Bioorganic & Medicinal Chemistry Letters. 14(20). 5227–5232. 17 indexed citations

14.

Mei, Jay, et al.. (2004). Multiplexed RT- PCR for High Throughput Screening Applications. Combinatorial Chemistry & High Throughput Screening. 7(8). 727–732. 8 indexed citations

15.

Ghosh, Shyamali, Rosemary J. Santulli, William A. Kinney, et al.. (2004). 1,2,3,4-Tetrahydroquinoline-containing αVβ3 integrin antagonists with enhanced oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 14(23). 5937–5941. 13 indexed citations

16.

Middleton, Steven A., Francis P. Barbone, Dana L. Johnson, et al.. (1999). Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide. Journal of Biological Chemistry. 274(20). 14163–14169. 47 indexed citations

17.

Johnson, Dana L., Francis X. Farrell, Francis P. Barbone, et al.. (1997). Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity. Chemistry & Biology. 4(12). 939–950. 46 indexed citations

18.

Middleton, Steven A., Dana L. Johnson, Frank J. McMahon, et al.. (1996). Identification of a Critical Ligand Binding Determinant of the Human Erythropoietin Receptor. Journal of Biological Chemistry. 271(24). 14045–14054. 49 indexed citations

19.

Johnson, Dana L., Robert J. Mullin, David S. Duch, & Stephen J. Benkovic. (1990). Direct demonstration of the active salvage of preformed purines by murine tumors. Biochemical and Biophysical Research Communications. 170(3). 1164–1169. 1 indexed citations

20.

Inglese, James, et al.. (1990). Subcloning, characterization, and affinity labeling of Escherichia coli glycinamide ribonucleotide transformylase. Biochemistry. 29(6). 1436–1443. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact